CD9 and hepatocellular carcinoma: Moreover, CD9 knockdown can suppress activation of JNK signaling pathway, which facilitates hepatocellular carcinoma cell proliferation by downstream cyclin D1 and Bcl-2 factors (Li et al., 2020).